|
|
Volumn 373, Issue 9670, 2009, Pages 1169-1170
|
|
Lymphadenectomy in endometrial cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER RECURRENCE;
CANCER RISK;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
ENDOMETRIUM CANCER;
HUMAN;
LETTER;
LYMPH NODE METASTASIS;
LYMPHADENECTOMY;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
ENDOMETRIUM TUMOR;
FEMALE;
METHODOLOGY;
MORTALITY;
NOTE;
PATHOLOGY;
PATIENT SELECTION;
PELVIS;
RISK FACTOR;
STATISTICS;
SURVIVAL RATE;
TREATMENT OUTCOME;
HYSTERECTOMY;
LAPAROSCOPY;
OVARIECTOMY;
RANDOMIZED CONTROLLED TRIAL;
ADJUVANT THERAPY;
ENDOMETRIAL NEOPLASMS;
FEMALE;
HUMANS;
LYMPH NODE EXCISION;
NEOPLASM STAGING;
PATIENT SELECTION;
PELVIS;
RESEARCH DESIGN;
RISK FACTORS;
SURVIVAL RATE;
TREATMENT OUTCOME;
HYSTERECTOMY;
LAPAROSCOPY;
OVARIECTOMY;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RADIOTHERAPY, ADJUVANT;
|
|
EID: 63349089068
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(09)60676-0 Document Type: Letter |
|
Times cited : (13)
|
|
References (5)
|
